ConductScience.org, home

Gene · 642

Papers2,639

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

201 to 220 of 2,639

Download this page as JSON
TitleJournalYearPMIDFound bySource
Ethnic inequities in the patterns of personalized care adjustments for 'informed dissent' and 'patient unsuitable': a retrospective study using Clinical Practice Research Datalink.J Public Health (Oxf)202337434314PubTator, text miningPubMed
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis.Neurotherapeutics202337430146PubTator, text miningPubMed
Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature.Syst Rev202337422656PubTator, text miningPubMed
Multi-population Black Hole Algorithm for the problem of data clustering.PLoS One202337406006PubTator, text miningPubMed
Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study.Pilot Feasibility Stud202337403145PubTator, text miningPubMed
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies.J Immunother Cancer202337399356PubTator, text miningPubMed
Evaluation of renal damage in a bleomycin-induced murine model of systemic sclerosis.Iran J Basic Med Sci202337396951PubTator, text miningPubMed
Response to A. Eleuteri regarding "A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules".EBioMedicine202337392598PubTator, text miningPubMed
Long-term impact of myocardial inflammation on quantitative myocardial perfusion-a descriptive PET/MR myocarditis study.Eur J Nucl Med Mol Imaging202337391545PubTator, text miningPubMed
Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients.Front Immunol202337377957PubTator, text miningPubMed
A Hybrid Parallel Balanced Phasmatodea Population Evolution Algorithm and Its Application in Workshop Material Scheduling.Entropy (Basel)202337372192PubTator, text miningPubMed
Filtering the rejection set while preserving false discovery rate control.J Am Stat Assoc202337346227PubTator, text miningPubMed
Development, successes, and potential pitfalls of multidisciplinary chronic disease management clinics in a family health team: a qualitative study.BMC Prim Care202337340362PubTator, text miningPubMed
Detection of sulfur mustard simulants using the microwave atmospheric pressure plasma optical emission spectroscopy method.Front Chem202337332893PubTator, text miningPubMed
A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism.BMJ Open202337328186PubTator, text miningPubMed
Pleomorphic undifferentiated sarcoma of the mediastinal thymus: A case report and literature review.Oncol Lett202337323820PubTator, text miningPubMed
Bipartite genome and structural organization of the parvovirus Acheta domesticus segmented densovirus.Nat Commun202337316488PubTator, text miningPubMed
Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.BMC Psychiatry202337312091PubTator, text miningPubMed
Understanding feeling "high" and its role in medical cannabis patient outcomes.Front Pharmacol202337292156PubTator, text miningPubMed
The monoaminergic system is a bilaterian innovation.Nat Commun202337280201PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/642/papers?page=11